Meet the Experts

James Conery, Principal Market Access

James Convery

Principal, Market Access

Strategic Market Access Insights That Strengthen Coverage and Accelerate Access

Real-World Perspectives from Payers, PBMs, SPs, and IDNs to Inform Smarter Strategy

Today’s access environment is increasingly complex. Payer expectations are evolving rapidly, and conventional assumptions around coverage, evidence, and approval criteria are no longer sufficient. Success requires more than compelling clinical data; it demands targeted strategy grounded in real-world stakeholder insights.

Herspiegel’s Strategic Market Access Insights Service empowers pharmaceutical manufacturers with the clarity to navigate the evolving access environment with confidence. We deliver insight-driven guidance by integrating perspectives from payers, PBMs, SPs, IDN decision makers, translating stakeholder expectations into meaningful market access strategies.

Our Approach

Transforming Stakeholder Perspectives into Strategic Direction

We go beyond traditional market research to uncover what truly drives access decisions. Our methodology blends qualitative and quantitative research, secondary research, advanced analytics, and input from our proprietary Herspiegel Advisor Network, a curated panel of 1,400+ vetted healthcare stakeholders.

This approach enables us to generate actionable insights that are both timely and strategically aligned. Whether preparing for launch, refining your value story, or adjusting to evolving payer dynamics, we provide the strategic foundation to move decisively.

What We Deliver

Our Market Access Insights Service supports strategic decision points throughout the product lifecycle:

  • Stakeholder insights to inform coverage strategy, pricing, and positioning
  • Flexible support for research design, data collection, analysis, and custom reporting
  • Advisory engagements including Mock P&T panels, payer workshops, and Strategic Working Groups
  • Rapid Response Survey Tool (RRST) for fast-turn, targeted insight generation
  • Competitive intelligence and access benchmarking
  • Advanced analytics and modeling to support scenario planning
Herspiegel Market Access Payer Insights Advisor Network

Why Herspiegel

Expert-Led. Insight-Rich. Strategy-Focused.

  • Supported 150+ launches across 15+ years
  • Multidisciplinary team with expertise in data science, behavioral strategy, and payer engagement
  • Long-term market access client relationships (average tenure ~7 years)
  • Access to 1,400+ vetted payers and decision-makers via the Herspiegel Advisor Network
  • Flexible support models: full-service project execution or targeted insight generation
  • Moderated engagements led by experienced strategists

Global Herspiegel Advisor Network

Through our Global Herspiegel Advisor Network, we deliver access to the decision-makers shaping market access strategy:

Health Plans

Engaging pharmacy, medical, and executive leaders across national, regional, and Blues plans—additionally, C-suite executives, quality directors and practice managers.

PBMs

Connecting with key pharmacy, contracting, and medical stakeholders at top U.S. pharmacy benefit managers.

IDNs

Reaching decision-makers across integrated delivery networks, including those with health plan components.

Global Decision Makers

Partnering with health economists, payer experts, academic experts, and former HTA leaders to shape global access strategy.

Herspiegel Payer Insights Stakeholders

Let’s Accelerate Your Access Strategy

Whether preparing for launch, responding to shifting payer dynamics, or enhancing pull-through, Herspiegel delivers strategic insight to unlock access and drive impact.

Download our Strategic Market Access Insights Overview

"*" indicates required fields

Full Name*

Connect with a Market Access Expert

If you would like to schedule time with one of our Market Access experts, click the link below:

Meet the Authors

James Conery, Principal Market Access

James Convery

Principal, Market Access

Let's Talk

Herspiegel is a leading professional services firm helping biotech start-ups and the world’s largest pharmaceutical companies navigate the path from science to brand performance and change patients’ lives. We are committed to using strategic insights from medical to commercial to market access to solve critical problems.